The Core of CHRETOWhat is CHRETO? It is my strategic business mindset for future joint ventures, entrepreneurships and job opportunities. The values within the CHRETO mindset are the cornerstones in my target mission and vision for future wins in and outside the biopharmaceutical area. CHRETO is also a management spin-out of Novozymes A/S, the world leader in industrial enzymes and is initially organized as a virtual company. CHRETO is led by a high performing management team of world class professionals. The management team is supported by CHRETO’s Network of more than twenty key opinion leaders and high level individuals from industry leading companies and academia within biopharmaceutical manufacturing.Field of excellence: How curiosity, intuition, unique knowledge and ideation can build the bridge into the future? My Answer: Maximize strategic wins and creative achievements with the power of cutting edge innovation, intuitive leadership and network as well as technical and biopharmaceutical business development.My accomplishments covers several inventions and innovations in various technology disciplines from the Semi Dry Electroblotting technology, which significantly improved the Western Blotting procedure, to robust enzymatic manufacturing procedures, through a nanotechnology based diagnostic method now recognized as the international standard for kidney failure, and latest the proprietary single use affinity purification technology that reduces the manufacturing cost and capacity problems in the biopharmaceutical industry.Specialties: Strategy & intuitive leadershipVirtual leadershipEntrepreneurshipProduct Life Cycle ManagementGlobal product managementStrategic planningBusiness developmentBiopharmaceutical ManufacturingProduct portfolio managementTechnical revolutionsCALLS FOR ACTION: Please contact me if you want to know more about CHRETO investment opportunities